Clinical Outcomes of Health Assessments 1st Jan – 31st Dec 2025

Reason for Audit:

The benefits of prevention rather than cure is clearly established in medical practice. However, there is an essential difference between screening programs for disease when applied to a population level which uses finite health resources versus preventive health assessments on an individual level. Echelon Health is solely focussed on the latter approach with our aim being to provide individual clients peace of mind that they have undergone the most advanced screening assessment for a range of specific diseases.  In order to demonstrate the validity of this approach, we have established this on-going audit of the results of our screening programmes in detecting early-stage disease.

Collection Process:

The records of all clients attending for a health assessment in 2025 were reviewed. There were a total of 416 clients: 257 men (age range 23-79 years; 118 were <50 yrs old and 138 >50) and 159 women (18-81 years; 82 were <50 yrs and 77 >50yrs). The clients had different health assessments.  Younger clients tended to have assessments of testes/ ovaries while older clients tended towards a comprehensive Platinum assessment.  Therefore, the results are expressed as number of cases of a disease/ number of clients undergoing a scan of that particular organ.

Analysis of Different Diseases/ Organs:

Coronary Heart Disease

Coronary heart disease (CHD) remains the most common cause of mortality in men aged 50-70 years in the UK with 300,000 individuals suffering a heart attack each year, of whom 125,00 die. Approximately half of these individuals have no risk factors and until now, have not been able to identify them so as to institute effective preventive measures. CHD is also the most common cause of death in post-menopausal women.

Measurement of coronary artery calcium (CAC) by CT scanning has been shown in multiple studies to offer a more accurate assessment of an individual’s risk of CHD disease than risk-factor derived models. The CAC score correlates strongly with the presence and severity of coronary atherosclerosis and allows the translation of population derived statistical risks to an individual CHD risk assessment. A zero score is indicative of no coronary atheromatous disease and should avoid the need for CHD prevention by statin therapy regardless of the statistical derived risk. Conversely, a positive score indicates the presence of atheromatous disease and thus the need for preventive therapy regardless of other surrogate markers such

as cholesterol levels. Scores greater than 100 have been shown to be associated with a 20-fold increased risk of future heart attack.

The CT coronary angiogram can accurately image the inside of coronary arteries with a resolution of 0.3mm and can identify areas of ‘furring up’ and quantify the degree of narrowing of the artery. In particular, this scan can determine the presence of ‘soft’ plaque which has not yet calcified and is more vulnerable to rupture. It is the rupture of plaques which results in a blood clot forming on the area of plaque causing a heart attack and ‘soft’ plaques are the main cause of sudden cardiac death.

CAC scores

Females

<50 yrs old

CAC score >90th centile for age matched population = 3/43 (6.9%)

>50 yrs old

CAC score >50th centile for age matched population = 4/59 (6.7%)

>75th centile = 5/59 (8.4%)

>90th centile = 6/59 (10.2%)

Males

Under 50 years

              >75th centile = 5/76 (6.5%)

>90th centile = 11.2%

One man aged 46 had a >90% blockage in all 3 of his coronary arteries with 2 smaller arteries being completely occluded. He was on no medications and had seen a cardiologist for a full check up 2 years before when he had been all was ‘normal’! However, he had not had a CTCA. He was immediately commenced on high strength medicines and urgently referred to a cardiologist whom he saw within 24 hours. He underwent coronary artery bypass grafting within a few days.

Over 50 years n=118,

>75th centile = 22.2%

>90th centile = 23.8%

33.8% had a CAC score >100 (associated with 20x increased risk of future heart attack)

The CT coronary angiogram (CTCA) images revealed 11.8% to have a narrowing of more than 50-75% in at least one artery while 19.4% of men had triple vessel disease.

Chest scans

The CT scanner is the only modality which can detect early lung cancers as small as 2mm and detection at this early stage allows for a >90% chance of surgical cure. Conversely if one waits for a lung cancer to be visible on a chest x-ray, the chance of cure is just 5-10%.

Women n = 102; Men n=140

Nodules were seen in 14.7% of women and 17.1% of men. Most of these can be classified as benign but some require follow up scanning to determine if they have grown in size. We follow the British Thoracic Society guidelines on which nodules should be followed up. Using these criteriae, a cancer was detected at follow scanning of a previous nodule in 2 men.

Ground glass shadowing, which can be a pre-cursor to future cancer development was seen in 4 clients.

Colon

Of the 77 women who underwent a CT virtual colonoscopy, 6 had a potentially pre-malignant colon polyp. This compared to 11.6% of the 129 men who underwent a VC and in 3 men (2.3%) it was larger than 10mm men which is considered to be high risk for an early cancer.

Abdomen and Pelvic scans

Benign liver cysts were observed in 20.7% of women and 10.8% of men. These require no further follow up.

Kidney cysts were seen in 12.6% women and 3.8% of men and again these need no follow up.

An adrenal gland tumour was seen in 2 clients.

Renal stones were seen in 2 clients.

Thyroid

A thyroid cyst or nodule was seen in 23/44 women <50 yrs and 35.7% of those >50 yrs. In men, the respective figures were 31.5% and 38% respectively.

A thyroid cancer was detected in 2.3% of clients.

Breast

A breast lump requiring further evaluation was seen in 3 women <50 yrs and 8 women >50 yrs of whom 1 had a cancer detected.

Ovaries and uterus

Ovarian cysts were reported in 20.2% of women <50 yrs and 7.4% of those >50 yrs. None were considered to be cancerous.

Fibroids were seen in 11.6% and 5.5% respectively.

Bone density

Osteopenia or osteoporosis was detected at the hip in 22.8% and at the spine in 35% of women aged >50 yrs.

In men >50 yrs, the corresponding figures were 6.8% and 42.5%.

Prostate

Of those men <50 yrs old, 11.1% had benign enlargement of the prostate gland compared to 85% of those aged >50. In the latter group, 2 clients had a prostate cancer detected.

Testes

A varicocele (enlargement of veins) was detected in 16.1% of men <50 yrs and 17.3% of those >50 yrs. They were considered to be severe in 3% and 5% respectively.

Epididymal cysts were seen in 10.1% and 13% respectively.

Brain

A brain tumour was recorded in 3 women and 1 man.

An aneurysm was seen in 14.4% and 16.6%. These were generally small and needed no treatment except for monitoring by repeat scanning. However, in 3 patients they were considered large enough to require urgent neurosurgical referral.

Evidence of a recent small intracerebral bleed was seen in 3 patients and potential demyelinating disease (multiple sclerosis) seen in 3 women and 1 male.

Significant vascular disease which would increase risk of a stroke and/or dementia was seen in 5 clients.

Evidence of a previous stroke was noted in 3 clients and in 1 man this was considered to be very recent and on-going. He was urgently referred to a stroke unit and received appropriate emergency care to prevent this from progressing to a catastrophic stroke.

Findings:

This on-going audit demonstrates the detection of early and sub-clinical disease in a significant proportion of individuals and confirms the clinical validity of offering advanced health assessments to individuals concerned about their health.